Figure 3.
Screening of RNAi target genes in BMSB adults by injection of dsRNA. One microgram of dsRNA targeting each of the 13 select genes, ATPase (Putative ATPase N2B, Acc. no: XM_014420983.1); PP1 (Serine/threonine-protein phosphatase PP1-beta catalytic subunit, Acc. no: XM_014431150.1); GPCR (G protein-coupled receptor 161-like, Acc. no. XM_014438952.1); IAP (Baculoviral IAP repeat-containing protein 7-B-like, Acc. no: XM_014435389.1); SNF7 (Charged multivesicular body protein 4b, Acc. no: XM_014427464.1); SRP (Signal recognition particle 54 kDa protein, Acc. no: XM_014419857.1); Actin (Actin-5C, Acc. no: XM_014433214.1); NSF (Alpha-soluble NSF attachment protein, Acc. no: XM_014434606.1); Kanesin (Uncharacterized Kanesin, Acc. no: XM_014426093.1.); Dynamin (Dynamin, Acc. no: XM_014433358.1); 26S (26S protease regulatory subunit 6B, Acc. no: XM_014421516.1); ROP (Protein ROP, Acc. no. XM_014418690.1); HSP70 (Heat shock 70 kDa protein cognate 3, Acc. no: XM_014425902.1) was injected into BMSB adults. The mortality was recorded on the 7th day after injection. dsRNA targeting gene coding for GFP was used as a control.